Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.
Please read the tutorial at this link: https://ebookbell.com/faq
We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.
For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.
EbookBell Team
4.4
32 reviews The book consists of 8 chapters; it first provides an introduction on biotransformation of xenobiotics, and then presents modern approaches and strategies for dealing with metabolite characterization, using tools such as LC-MS, H-D exchange, stable isotopes LC-MS-NMR, and radiolabeled compounds. Also, strategies for dealing with reactive intermediates in drug discovery and development are presented as well as case studies on improving the decision-making process in the structural modification of drug candidates. The last chapter discusses the regulatory perspectives of safety testing of drug metabolites and why, how, and when to test their safety.Content:
Chapter 1 Human Biotransformation (pages 1–77): Andrew Parkinson, Brian W. Ogilvie, Brandy L. Paris, Tiffini N. Hensley and Greg J. Loewen
Chapter 2 Analytical Tools and Approaches for Metabolite Identification in Drug Metabolism (pages 79–123): Yongmei Li
Chapter 3 Tools of Choice for Accelerating Metabolite Identification: Mass Spectrometry Technology Drives Metabolite Identification Studies Forward (pages 125–162): Ala F. Nassar
Chapter 4 Improving Drug Design: Considerations for the Structural Modification Process (pages 163–216): Ala F. Nassar
Chapter 5 Case Study: The Unanticipated Loss of N2 from Novel DNA Alkylating Agent Laromustine by Collision?Induced Dissociation: Novel Rearrangements (pages 217–228): Ala F. Nassar, Jing Du, David Roberts, Kevin Lin, Mike Belcourt, Ivan King and Tukiet T. Lam
Chapter 6 Case Study: Identification of in vitro Metabolite/Decomposition Products of the Novel DNA Alkylating Agent Laromustine (pages 229–244): Ala F. Nassar, Jing Du, David Roberts, Kevin Lin, Mike Belcourt, Ivan King and Tukiet T. Lam
Chapter 7 Strategies for the Detection of Reactive Intermediates in Drug Discovery and Development (pages 245–294): Mark P. Grillo
Chapter 8 Safety Testing of Drug Metabolites: Mist Guidance Impact on the Practice of Industrial Drug Metabolism (pages 295–312): J. Greg Slatter
